Jeremy Chaikind is an Assistant Professor in the Department of Psychiatry & Behavioral Sciences. He specializes in using device-based treatments and advanced psychopharmacology to help patients with severe and resistant mental illness, particularly treatment-resistant depression. He began working in the Interventional Psychiatry Lab while completing a fellowship in Neuromodulation Medicine at the University of Minnesota, and he was inspired by how psychiatry's growing understanding of the different networks in the brain could be applied to help even the patients for whom no other treatments had worked. Now in a faculty role, he serves as a study clinician and clinical advisor for research studies involving vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS), focal electrically administered seizure therapy (FEAST), and personalized and adaptive cortical electro-stimulation (PACE).
